nodes	percent_of_prediction	percent_of_DWPC	metapath
Imipramine—attention deficit hyperactivity disorder—Clonidine—glaucoma	0.399	1	CpDpCtD
Imipramine—SLC22A1—Latanoprost—glaucoma	0.0324	0.076	CbGbCtD
Imipramine—CHRM3—Carbachol—glaucoma	0.0261	0.0612	CbGbCtD
Imipramine—SLC22A4—Clonidine—glaucoma	0.0257	0.0601	CbGbCtD
Imipramine—CHRM3—Pilocarpine—glaucoma	0.0243	0.0569	CbGbCtD
Imipramine—ADRA1A—Apraclonidine—glaucoma	0.0241	0.0564	CbGbCtD
Imipramine—SLC22A3—Clonidine—glaucoma	0.0234	0.0547	CbGbCtD
Imipramine—CHRM1—Carbachol—glaucoma	0.0227	0.0532	CbGbCtD
Imipramine—CHRM1—Pilocarpine—glaucoma	0.0211	0.0495	CbGbCtD
Imipramine—CHRM2—Carbachol—glaucoma	0.0209	0.0491	CbGbCtD
Imipramine—CHRM2—Pilocarpine—glaucoma	0.0195	0.0456	CbGbCtD
Imipramine—ADRA1A—Dipivefrin—glaucoma	0.0192	0.0451	CbGbCtD
Imipramine—ADRA1D—Clonidine—glaucoma	0.0174	0.0408	CbGbCtD
Imipramine—CYP2E1—Pilocarpine—glaucoma	0.0149	0.0349	CbGbCtD
Imipramine—ADRA1B—Clonidine—glaucoma	0.0127	0.0297	CbGbCtD
Imipramine—SLC22A1—Clonidine—glaucoma	0.012	0.0281	CbGbCtD
Imipramine—SLC6A2—Clonidine—glaucoma	0.0116	0.0271	CbGbCtD
Imipramine—CYP2E1—Methazolamide—glaucoma	0.0101	0.0236	CbGbCtD
Imipramine—ADRA1A—Clonidine—glaucoma	0.00999	0.0234	CbGbCtD
Imipramine—CYP2D6—Carteolol—glaucoma	0.00937	0.0219	CbGbCtD
Imipramine—CYP1A2—Betaxolol—glaucoma	0.00768	0.018	CbGbCtD
Imipramine—CYP2D6—Betaxolol—glaucoma	0.00633	0.0148	CbGbCtD
Imipramine—CYP2C19—Methazolamide—glaucoma	0.00631	0.0148	CbGbCtD
Imipramine—CYP2C19—Timolol—glaucoma	0.00536	0.0126	CbGbCtD
Imipramine—CYP2D6—Methazolamide—glaucoma	0.0048	0.0112	CbGbCtD
Imipramine—CYP3A4—Pilocarpine—glaucoma	0.00451	0.0106	CbGbCtD
Imipramine—ABCB1—Timolol—glaucoma	0.00433	0.0101	CbGbCtD
Imipramine—CYP1A2—Clonidine—glaucoma	0.00421	0.00986	CbGbCtD
Imipramine—CYP2D6—Timolol—glaucoma	0.00408	0.00955	CbGbCtD
Imipramine—ABCB1—Clonidine—glaucoma	0.00368	0.00862	CbGbCtD
Imipramine—CYP3A4—Brinzolamide—glaucoma	0.00354	0.0083	CbGbCtD
Imipramine—CYP2D6—Clonidine—glaucoma	0.00347	0.00812	CbGbCtD
Imipramine—CYP3A4—Dorzolamide—glaucoma	0.00342	0.00802	CbGbCtD
Imipramine—CYP3A4—Methazolamide—glaucoma	0.00305	0.00715	CbGbCtD
Imipramine—CYP3A4—Acetazolamide—glaucoma	0.00244	0.00571	CbGbCtD
Imipramine—CYP3A4—Clonidine—glaucoma	0.0022	0.00517	CbGbCtD
Imipramine—Amitriptyline—NTRK2—glaucoma	0.00035	0.395	CrCbGaD
Imipramine—Benazepril—MTHFR—glaucoma	0.000321	0.362	CrCbGaD
Imipramine—Amitriptyline—NTRK1—glaucoma	0.000216	0.244	CrCbGaD
Imipramine—Dyspepsia—Travoprost—glaucoma	0.000102	0.000812	CcSEcCtD
Imipramine—Asthenia—Apraclonidine—glaucoma	0.000102	0.000811	CcSEcCtD
Imipramine—Somnolence—Brinzolamide—glaucoma	0.000102	0.00081	CcSEcCtD
Imipramine—Vision blurred—Clonidine—glaucoma	0.000101	0.000807	CcSEcCtD
Imipramine—Decreased appetite—Dorzolamide—glaucoma	0.000101	0.000805	CcSEcCtD
Imipramine—Erectile dysfunction—Timolol—glaucoma	0.000101	0.000805	CcSEcCtD
Imipramine—Urticaria—Acetazolamide—glaucoma	0.000101	0.000803	CcSEcCtD
Imipramine—Tremor—Clonidine—glaucoma	0.000101	0.000802	CcSEcCtD
Imipramine—Dyspepsia—Brinzolamide—glaucoma	0.000101	0.000802	CcSEcCtD
Imipramine—Eye disorder—Betaxolol—glaucoma	0.000101	0.000801	CcSEcCtD
Imipramine—Pruritus—Apraclonidine—glaucoma	0.0001	0.000799	CcSEcCtD
Imipramine—Body temperature increased—Acetazolamide—glaucoma	0.0001	0.000799	CcSEcCtD
Imipramine—Fatigue—Dorzolamide—glaucoma	0.0001	0.000799	CcSEcCtD
Imipramine—Tinnitus—Betaxolol—glaucoma	0.0001	0.000799	CcSEcCtD
Imipramine—Gastrointestinal disorder—Travoprost—glaucoma	0.0001	0.000796	CcSEcCtD
Imipramine—Fatigue—Travoprost—glaucoma	9.99e-05	0.000795	CcSEcCtD
Imipramine—Flushing—Betaxolol—glaucoma	9.99e-05	0.000795	CcSEcCtD
Imipramine—Cardiac disorder—Betaxolol—glaucoma	9.99e-05	0.000795	CcSEcCtD
Imipramine—Ill-defined disorder—Clonidine—glaucoma	9.98e-05	0.000795	CcSEcCtD
Imipramine—Insomnia—Pilocarpine—glaucoma	9.95e-05	0.000792	CcSEcCtD
Imipramine—Decreased appetite—Brinzolamide—glaucoma	9.95e-05	0.000792	CcSEcCtD
Imipramine—Weight decreased—Timolol—glaucoma	9.94e-05	0.000791	CcSEcCtD
Imipramine—Constipation—Travoprost—glaucoma	9.91e-05	0.000789	CcSEcCtD
Imipramine—Agitation—Clonidine—glaucoma	9.89e-05	0.000787	CcSEcCtD
Imipramine—Gastrointestinal disorder—Brinzolamide—glaucoma	9.88e-05	0.000786	CcSEcCtD
Imipramine—Paraesthesia—Pilocarpine—glaucoma	9.88e-05	0.000786	CcSEcCtD
Imipramine—Asthenia—Bimatoprost—glaucoma	9.87e-05	0.000786	CcSEcCtD
Imipramine—Fatigue—Brinzolamide—glaucoma	9.86e-05	0.000785	CcSEcCtD
Imipramine—Somnolence—Pilocarpine—glaucoma	9.78e-05	0.000778	CcSEcCtD
Imipramine—Angiopathy—Betaxolol—glaucoma	9.76e-05	0.000777	CcSEcCtD
Imipramine—Pruritus—Bimatoprost—glaucoma	9.74e-05	0.000775	CcSEcCtD
Imipramine—Immune system disorder—Betaxolol—glaucoma	9.72e-05	0.000774	CcSEcCtD
Imipramine—Diarrhoea—Apraclonidine—glaucoma	9.71e-05	0.000773	CcSEcCtD
Imipramine—Malaise—Clonidine—glaucoma	9.7e-05	0.000772	CcSEcCtD
Imipramine—Mediastinal disorder—Betaxolol—glaucoma	9.7e-05	0.000772	CcSEcCtD
Imipramine—Dyspepsia—Pilocarpine—glaucoma	9.68e-05	0.000771	CcSEcCtD
Imipramine—Syncope—Clonidine—glaucoma	9.65e-05	0.000768	CcSEcCtD
Imipramine—Arrhythmia—Betaxolol—glaucoma	9.61e-05	0.000765	CcSEcCtD
Imipramine—Feeling abnormal—Dorzolamide—glaucoma	9.59e-05	0.000763	CcSEcCtD
Imipramine—Decreased appetite—Pilocarpine—glaucoma	9.56e-05	0.000761	CcSEcCtD
Imipramine—Feeling abnormal—Travoprost—glaucoma	9.55e-05	0.00076	CcSEcCtD
Imipramine—Gastrointestinal pain—Dorzolamide—glaucoma	9.52e-05	0.000758	CcSEcCtD
Imipramine—Alopecia—Betaxolol—glaucoma	9.51e-05	0.000757	CcSEcCtD
Imipramine—Palpitations—Clonidine—glaucoma	9.51e-05	0.000757	CcSEcCtD
Imipramine—Gastrointestinal disorder—Pilocarpine—glaucoma	9.49e-05	0.000756	CcSEcCtD
Imipramine—Gastrointestinal pain—Travoprost—glaucoma	9.48e-05	0.000754	CcSEcCtD
Imipramine—Loss of consciousness—Clonidine—glaucoma	9.46e-05	0.000753	CcSEcCtD
Imipramine—Feeling abnormal—Brinzolamide—glaucoma	9.43e-05	0.000751	CcSEcCtD
Imipramine—Mental disorder—Betaxolol—glaucoma	9.43e-05	0.00075	CcSEcCtD
Imipramine—Constipation—Pilocarpine—glaucoma	9.4e-05	0.000749	CcSEcCtD
Imipramine—Dizziness—Apraclonidine—glaucoma	9.39e-05	0.000747	CcSEcCtD
Imipramine—Malnutrition—Betaxolol—glaucoma	9.37e-05	0.000746	CcSEcCtD
Imipramine—Urticaria—Dorzolamide—glaucoma	9.25e-05	0.000736	CcSEcCtD
Imipramine—Abdominal pain—Dorzolamide—glaucoma	9.2e-05	0.000732	CcSEcCtD
Imipramine—Body temperature increased—Dorzolamide—glaucoma	9.2e-05	0.000732	CcSEcCtD
Imipramine—Tension—Betaxolol—glaucoma	9.19e-05	0.000732	CcSEcCtD
Imipramine—Dysgeusia—Betaxolol—glaucoma	9.17e-05	0.00073	CcSEcCtD
Imipramine—Abdominal pain—Travoprost—glaucoma	9.16e-05	0.000729	CcSEcCtD
Imipramine—Agranulocytosis—Timolol—glaucoma	9.14e-05	0.000727	CcSEcCtD
Imipramine—Anxiety—Clonidine—glaucoma	9.13e-05	0.000727	CcSEcCtD
Imipramine—Asthenia—Acetazolamide—glaucoma	9.11e-05	0.000725	CcSEcCtD
Imipramine—Dizziness—Bimatoprost—glaucoma	9.1e-05	0.000724	CcSEcCtD
Imipramine—Nervousness—Betaxolol—glaucoma	9.1e-05	0.000724	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	9.1e-05	0.000724	CcSEcCtD
Imipramine—Urticaria—Brinzolamide—glaucoma	9.09e-05	0.000724	CcSEcCtD
Imipramine—Feeling abnormal—Pilocarpine—glaucoma	9.06e-05	0.000721	CcSEcCtD
Imipramine—Discomfort—Clonidine—glaucoma	9.05e-05	0.00072	CcSEcCtD
Imipramine—Vomiting—Apraclonidine—glaucoma	9.03e-05	0.000718	CcSEcCtD
Imipramine—Gastrointestinal pain—Pilocarpine—glaucoma	8.99e-05	0.000716	CcSEcCtD
Imipramine—Dry mouth—Clonidine—glaucoma	8.96e-05	0.000713	CcSEcCtD
Imipramine—Dermatitis—Apraclonidine—glaucoma	8.94e-05	0.000712	CcSEcCtD
Imipramine—Headache—Apraclonidine—glaucoma	8.89e-05	0.000708	CcSEcCtD
Imipramine—Confusional state—Clonidine—glaucoma	8.86e-05	0.000705	CcSEcCtD
Imipramine—Vision blurred—Betaxolol—glaucoma	8.83e-05	0.000703	CcSEcCtD
Imipramine—Oedema—Clonidine—glaucoma	8.78e-05	0.000699	CcSEcCtD
Imipramine—Tremor—Betaxolol—glaucoma	8.78e-05	0.000699	CcSEcCtD
Imipramine—Hallucination—Timolol—glaucoma	8.75e-05	0.000696	CcSEcCtD
Imipramine—Asthenia—Brimonidine—glaucoma	8.74e-05	0.000696	CcSEcCtD
Imipramine—Infection—Clonidine—glaucoma	8.73e-05	0.000694	CcSEcCtD
Imipramine—Abdominal pain—Pilocarpine—glaucoma	8.69e-05	0.000692	CcSEcCtD
Imipramine—Body temperature increased—Pilocarpine—glaucoma	8.69e-05	0.000692	CcSEcCtD
Imipramine—Ill-defined disorder—Betaxolol—glaucoma	8.69e-05	0.000692	CcSEcCtD
Imipramine—Diarrhoea—Acetazolamide—glaucoma	8.69e-05	0.000692	CcSEcCtD
Imipramine—Rash—Bimatoprost—glaucoma	8.68e-05	0.000691	CcSEcCtD
Imipramine—Dermatitis—Bimatoprost—glaucoma	8.67e-05	0.00069	CcSEcCtD
Imipramine—Shock—Clonidine—glaucoma	8.64e-05	0.000688	CcSEcCtD
Imipramine—Pruritus—Brimonidine—glaucoma	8.62e-05	0.000686	CcSEcCtD
Imipramine—Headache—Bimatoprost—glaucoma	8.62e-05	0.000686	CcSEcCtD
Imipramine—Nervous system disorder—Clonidine—glaucoma	8.61e-05	0.000686	CcSEcCtD
Imipramine—Thrombocytopenia—Clonidine—glaucoma	8.6e-05	0.000684	CcSEcCtD
Imipramine—Tachycardia—Clonidine—glaucoma	8.57e-05	0.000682	CcSEcCtD
Imipramine—Skin disorder—Clonidine—glaucoma	8.53e-05	0.000679	CcSEcCtD
Imipramine—Hyperhidrosis—Clonidine—glaucoma	8.49e-05	0.000676	CcSEcCtD
Imipramine—Malaise—Betaxolol—glaucoma	8.45e-05	0.000672	CcSEcCtD
Imipramine—Nausea—Apraclonidine—glaucoma	8.43e-05	0.000671	CcSEcCtD
Imipramine—Syncope—Betaxolol—glaucoma	8.4e-05	0.000669	CcSEcCtD
Imipramine—Dizziness—Acetazolamide—glaucoma	8.4e-05	0.000668	CcSEcCtD
Imipramine—Anorexia—Clonidine—glaucoma	8.37e-05	0.000666	CcSEcCtD
Imipramine—Asthenia—Dorzolamide—glaucoma	8.35e-05	0.000665	CcSEcCtD
Imipramine—Asthenia—Travoprost—glaucoma	8.31e-05	0.000662	CcSEcCtD
Imipramine—Palpitations—Betaxolol—glaucoma	8.28e-05	0.000659	CcSEcCtD
Imipramine—Pruritus—Dorzolamide—glaucoma	8.23e-05	0.000655	CcSEcCtD
Imipramine—Loss of consciousness—Betaxolol—glaucoma	8.23e-05	0.000655	CcSEcCtD
Imipramine—Eye disorder—Timolol—glaucoma	8.22e-05	0.000654	CcSEcCtD
Imipramine—Asthenia—Brinzolamide—glaucoma	8.21e-05	0.000653	CcSEcCtD
Imipramine—Pruritus—Travoprost—glaucoma	8.2e-05	0.000653	CcSEcCtD
Imipramine—Tinnitus—Timolol—glaucoma	8.2e-05	0.000652	CcSEcCtD
Imipramine—Nausea—Bimatoprost—glaucoma	8.18e-05	0.000651	CcSEcCtD
Imipramine—Cardiac disorder—Timolol—glaucoma	8.16e-05	0.000649	CcSEcCtD
Imipramine—Pruritus—Brinzolamide—glaucoma	8.1e-05	0.000644	CcSEcCtD
Imipramine—Vomiting—Acetazolamide—glaucoma	8.07e-05	0.000643	CcSEcCtD
Imipramine—Dizziness—Brimonidine—glaucoma	8.06e-05	0.000641	CcSEcCtD
Imipramine—Angiopathy—Timolol—glaucoma	7.98e-05	0.000635	CcSEcCtD
Imipramine—Diarrhoea—Dorzolamide—glaucoma	7.96e-05	0.000634	CcSEcCtD
Imipramine—Headache—Acetazolamide—glaucoma	7.95e-05	0.000633	CcSEcCtD
Imipramine—Anxiety—Betaxolol—glaucoma	7.95e-05	0.000633	CcSEcCtD
Imipramine—Insomnia—Clonidine—glaucoma	7.94e-05	0.000632	CcSEcCtD
Imipramine—Immune system disorder—Timolol—glaucoma	7.94e-05	0.000632	CcSEcCtD
Imipramine—Diarrhoea—Travoprost—glaucoma	7.93e-05	0.000631	CcSEcCtD
Imipramine—Mediastinal disorder—Timolol—glaucoma	7.92e-05	0.000631	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	7.92e-05	0.00063	CcSEcCtD
Imipramine—Asthenia—Pilocarpine—glaucoma	7.89e-05	0.000628	CcSEcCtD
Imipramine—Paraesthesia—Clonidine—glaucoma	7.89e-05	0.000628	CcSEcCtD
Imipramine—Discomfort—Betaxolol—glaucoma	7.88e-05	0.000627	CcSEcCtD
Imipramine—Arrhythmia—Timolol—glaucoma	7.85e-05	0.000625	CcSEcCtD
Imipramine—Diarrhoea—Brinzolamide—glaucoma	7.83e-05	0.000623	CcSEcCtD
Imipramine—Somnolence—Clonidine—glaucoma	7.81e-05	0.000621	CcSEcCtD
Imipramine—Dry mouth—Betaxolol—glaucoma	7.8e-05	0.000621	CcSEcCtD
Imipramine—Pruritus—Pilocarpine—glaucoma	7.78e-05	0.000619	CcSEcCtD
Imipramine—Alopecia—Timolol—glaucoma	7.77e-05	0.000618	CcSEcCtD
Imipramine—Confusional state—Betaxolol—glaucoma	7.71e-05	0.000614	CcSEcCtD
Imipramine—Mental disorder—Timolol—glaucoma	7.7e-05	0.000613	CcSEcCtD
Imipramine—Dizziness—Dorzolamide—glaucoma	7.7e-05	0.000613	CcSEcCtD
Imipramine—Rash—Brimonidine—glaucoma	7.68e-05	0.000612	CcSEcCtD
Imipramine—Dermatitis—Brimonidine—glaucoma	7.68e-05	0.000611	CcSEcCtD
Imipramine—Dizziness—Travoprost—glaucoma	7.66e-05	0.00061	CcSEcCtD
Imipramine—Malnutrition—Timolol—glaucoma	7.65e-05	0.000609	CcSEcCtD
Imipramine—Oedema—Betaxolol—glaucoma	7.65e-05	0.000609	CcSEcCtD
Imipramine—Headache—Brimonidine—glaucoma	7.63e-05	0.000608	CcSEcCtD
Imipramine—Decreased appetite—Clonidine—glaucoma	7.63e-05	0.000608	CcSEcCtD
Imipramine—Infection—Betaxolol—glaucoma	7.6e-05	0.000605	CcSEcCtD
Imipramine—Gastrointestinal disorder—Clonidine—glaucoma	7.58e-05	0.000604	CcSEcCtD
Imipramine—Fatigue—Clonidine—glaucoma	7.57e-05	0.000603	CcSEcCtD
Imipramine—Dizziness—Brinzolamide—glaucoma	7.57e-05	0.000602	CcSEcCtD
Imipramine—Nausea—Acetazolamide—glaucoma	7.54e-05	0.0006	CcSEcCtD
Imipramine—Diarrhoea—Pilocarpine—glaucoma	7.52e-05	0.000599	CcSEcCtD
Imipramine—Shock—Betaxolol—glaucoma	7.52e-05	0.000599	CcSEcCtD
Imipramine—Tension—Timolol—glaucoma	7.51e-05	0.000598	CcSEcCtD
Imipramine—Constipation—Clonidine—glaucoma	7.51e-05	0.000598	CcSEcCtD
Imipramine—Nervous system disorder—Betaxolol—glaucoma	7.5e-05	0.000597	CcSEcCtD
Imipramine—Dysgeusia—Timolol—glaucoma	7.49e-05	0.000597	CcSEcCtD
Imipramine—Thrombocytopenia—Betaxolol—glaucoma	7.49e-05	0.000596	CcSEcCtD
Imipramine—Tachycardia—Betaxolol—glaucoma	7.46e-05	0.000594	CcSEcCtD
Imipramine—Nervousness—Timolol—glaucoma	7.43e-05	0.000592	CcSEcCtD
Imipramine—Skin disorder—Betaxolol—glaucoma	7.43e-05	0.000591	CcSEcCtD
Imipramine—Vomiting—Dorzolamide—glaucoma	7.4e-05	0.000589	CcSEcCtD
Imipramine—Hyperhidrosis—Betaxolol—glaucoma	7.39e-05	0.000588	CcSEcCtD
Imipramine—Rash—Dorzolamide—glaucoma	7.34e-05	0.000584	CcSEcCtD
Imipramine—Dermatitis—Dorzolamide—glaucoma	7.33e-05	0.000584	CcSEcCtD
Imipramine—Rash—Travoprost—glaucoma	7.31e-05	0.000582	CcSEcCtD
Imipramine—Dermatitis—Travoprost—glaucoma	7.3e-05	0.000581	CcSEcCtD
Imipramine—Headache—Dorzolamide—glaucoma	7.29e-05	0.00058	CcSEcCtD
Imipramine—Anorexia—Betaxolol—glaucoma	7.29e-05	0.00058	CcSEcCtD
Imipramine—Vomiting—Brinzolamide—glaucoma	7.28e-05	0.000579	CcSEcCtD
Imipramine—Dizziness—Pilocarpine—glaucoma	7.27e-05	0.000579	CcSEcCtD
Imipramine—Headache—Travoprost—glaucoma	7.26e-05	0.000578	CcSEcCtD
Imipramine—Nausea—Brimonidine—glaucoma	7.24e-05	0.000576	CcSEcCtD
Imipramine—Feeling abnormal—Clonidine—glaucoma	7.24e-05	0.000576	CcSEcCtD
Imipramine—Rash—Brinzolamide—glaucoma	7.21e-05	0.000574	CcSEcCtD
Imipramine—Vision blurred—Timolol—glaucoma	7.21e-05	0.000574	CcSEcCtD
Imipramine—Dermatitis—Brinzolamide—glaucoma	7.21e-05	0.000574	CcSEcCtD
Imipramine—Gastrointestinal pain—Clonidine—glaucoma	7.18e-05	0.000572	CcSEcCtD
Imipramine—Headache—Brinzolamide—glaucoma	7.17e-05	0.000571	CcSEcCtD
Imipramine—Vomiting—Pilocarpine—glaucoma	6.99e-05	0.000557	CcSEcCtD
Imipramine—Urticaria—Clonidine—glaucoma	6.98e-05	0.000555	CcSEcCtD
Imipramine—Abdominal pain—Clonidine—glaucoma	6.94e-05	0.000553	CcSEcCtD
Imipramine—Body temperature increased—Clonidine—glaucoma	6.94e-05	0.000553	CcSEcCtD
Imipramine—Rash—Pilocarpine—glaucoma	6.93e-05	0.000552	CcSEcCtD
Imipramine—Dermatitis—Pilocarpine—glaucoma	6.93e-05	0.000551	CcSEcCtD
Imipramine—Insomnia—Betaxolol—glaucoma	6.92e-05	0.00055	CcSEcCtD
Imipramine—Nausea—Dorzolamide—glaucoma	6.91e-05	0.00055	CcSEcCtD
Imipramine—Headache—Pilocarpine—glaucoma	6.89e-05	0.000548	CcSEcCtD
Imipramine—Nausea—Travoprost—glaucoma	6.88e-05	0.000548	CcSEcCtD
Imipramine—Paraesthesia—Betaxolol—glaucoma	6.87e-05	0.000546	CcSEcCtD
Imipramine—Syncope—Timolol—glaucoma	6.86e-05	0.000546	CcSEcCtD
Imipramine—Nausea—Brinzolamide—glaucoma	6.8e-05	0.000541	CcSEcCtD
Imipramine—Palpitations—Timolol—glaucoma	6.76e-05	0.000538	CcSEcCtD
Imipramine—Dyspepsia—Betaxolol—glaucoma	6.73e-05	0.000536	CcSEcCtD
Imipramine—Loss of consciousness—Timolol—glaucoma	6.73e-05	0.000535	CcSEcCtD
Imipramine—Decreased appetite—Betaxolol—glaucoma	6.65e-05	0.000529	CcSEcCtD
Imipramine—Hypertension—Timolol—glaucoma	6.61e-05	0.000526	CcSEcCtD
Imipramine—Gastrointestinal disorder—Betaxolol—glaucoma	6.6e-05	0.000525	CcSEcCtD
Imipramine—Fatigue—Betaxolol—glaucoma	6.59e-05	0.000525	CcSEcCtD
Imipramine—Constipation—Betaxolol—glaucoma	6.54e-05	0.00052	CcSEcCtD
Imipramine—Nausea—Pilocarpine—glaucoma	6.53e-05	0.00052	CcSEcCtD
Imipramine—Anxiety—Timolol—glaucoma	6.49e-05	0.000517	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	6.47e-05	0.000515	CcSEcCtD
Imipramine—Discomfort—Timolol—glaucoma	6.44e-05	0.000512	CcSEcCtD
Imipramine—Dry mouth—Timolol—glaucoma	6.37e-05	0.000507	CcSEcCtD
Imipramine—Asthenia—Clonidine—glaucoma	6.3e-05	0.000502	CcSEcCtD
Imipramine—Feeling abnormal—Betaxolol—glaucoma	6.3e-05	0.000502	CcSEcCtD
Imipramine—Confusional state—Timolol—glaucoma	6.3e-05	0.000501	CcSEcCtD
Imipramine—Anaphylactic shock—Timolol—glaucoma	6.25e-05	0.000497	CcSEcCtD
Imipramine—Oedema—Timolol—glaucoma	6.25e-05	0.000497	CcSEcCtD
Imipramine—Pruritus—Clonidine—glaucoma	6.21e-05	0.000495	CcSEcCtD
Imipramine—Infection—Timolol—glaucoma	6.21e-05	0.000494	CcSEcCtD
Imipramine—Shock—Timolol—glaucoma	6.15e-05	0.000489	CcSEcCtD
Imipramine—Nervous system disorder—Timolol—glaucoma	6.13e-05	0.000488	CcSEcCtD
Imipramine—Urticaria—Betaxolol—glaucoma	6.07e-05	0.000483	CcSEcCtD
Imipramine—Skin disorder—Timolol—glaucoma	6.07e-05	0.000483	CcSEcCtD
Imipramine—Body temperature increased—Betaxolol—glaucoma	6.04e-05	0.000481	CcSEcCtD
Imipramine—Hyperhidrosis—Timolol—glaucoma	6.04e-05	0.000481	CcSEcCtD
Imipramine—Diarrhoea—Clonidine—glaucoma	6.01e-05	0.000478	CcSEcCtD
Imipramine—Anorexia—Timolol—glaucoma	5.95e-05	0.000474	CcSEcCtD
Imipramine—Dizziness—Clonidine—glaucoma	5.81e-05	0.000462	CcSEcCtD
Imipramine—Insomnia—Timolol—glaucoma	5.65e-05	0.00045	CcSEcCtD
Imipramine—Paraesthesia—Timolol—glaucoma	5.61e-05	0.000446	CcSEcCtD
Imipramine—Vomiting—Clonidine—glaucoma	5.58e-05	0.000444	CcSEcCtD
Imipramine—Somnolence—Timolol—glaucoma	5.55e-05	0.000442	CcSEcCtD
Imipramine—Rash—Clonidine—glaucoma	5.54e-05	0.000441	CcSEcCtD
Imipramine—Dermatitis—Clonidine—glaucoma	5.53e-05	0.00044	CcSEcCtD
Imipramine—Headache—Clonidine—glaucoma	5.5e-05	0.000438	CcSEcCtD
Imipramine—Dyspepsia—Timolol—glaucoma	5.5e-05	0.000438	CcSEcCtD
Imipramine—Asthenia—Betaxolol—glaucoma	5.49e-05	0.000437	CcSEcCtD
Imipramine—Decreased appetite—Timolol—glaucoma	5.43e-05	0.000432	CcSEcCtD
Imipramine—Pruritus—Betaxolol—glaucoma	5.41e-05	0.000431	CcSEcCtD
Imipramine—Gastrointestinal disorder—Timolol—glaucoma	5.39e-05	0.000429	CcSEcCtD
Imipramine—Fatigue—Timolol—glaucoma	5.39e-05	0.000429	CcSEcCtD
Imipramine—Diarrhoea—Betaxolol—glaucoma	5.23e-05	0.000416	CcSEcCtD
Imipramine—Nausea—Clonidine—glaucoma	5.22e-05	0.000415	CcSEcCtD
Imipramine—Feeling abnormal—Timolol—glaucoma	5.15e-05	0.00041	CcSEcCtD
Imipramine—Gastrointestinal pain—Timolol—glaucoma	5.11e-05	0.000407	CcSEcCtD
Imipramine—Dizziness—Betaxolol—glaucoma	5.06e-05	0.000402	CcSEcCtD
Imipramine—Urticaria—Timolol—glaucoma	4.96e-05	0.000395	CcSEcCtD
Imipramine—Abdominal pain—Timolol—glaucoma	4.94e-05	0.000393	CcSEcCtD
Imipramine—Body temperature increased—Timolol—glaucoma	4.94e-05	0.000393	CcSEcCtD
Imipramine—Vomiting—Betaxolol—glaucoma	4.86e-05	0.000387	CcSEcCtD
Imipramine—Rash—Betaxolol—glaucoma	4.82e-05	0.000384	CcSEcCtD
Imipramine—Dermatitis—Betaxolol—glaucoma	4.82e-05	0.000383	CcSEcCtD
Imipramine—Headache—Betaxolol—glaucoma	4.79e-05	0.000381	CcSEcCtD
Imipramine—Nausea—Betaxolol—glaucoma	4.54e-05	0.000361	CcSEcCtD
Imipramine—Asthenia—Timolol—glaucoma	4.48e-05	0.000357	CcSEcCtD
Imipramine—Pruritus—Timolol—glaucoma	4.42e-05	0.000352	CcSEcCtD
Imipramine—Diarrhoea—Timolol—glaucoma	4.27e-05	0.00034	CcSEcCtD
Imipramine—Dizziness—Timolol—glaucoma	4.13e-05	0.000329	CcSEcCtD
Imipramine—Vomiting—Timolol—glaucoma	3.97e-05	0.000316	CcSEcCtD
Imipramine—Rash—Timolol—glaucoma	3.94e-05	0.000313	CcSEcCtD
Imipramine—Dermatitis—Timolol—glaucoma	3.93e-05	0.000313	CcSEcCtD
Imipramine—Headache—Timolol—glaucoma	3.91e-05	0.000311	CcSEcCtD
Imipramine—Nausea—Timolol—glaucoma	3.71e-05	0.000295	CcSEcCtD
Imipramine—ADRA1D—Signaling Pathways—C3—glaucoma	4.22e-06	8.78e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—EDN1—glaucoma	4.21e-06	8.76e-05	CbGpPWpGaD
Imipramine—CYP2C18—Metabolism—PTGS2—glaucoma	4.2e-06	8.75e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—EDN1—glaucoma	4.19e-06	8.72e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—NTRK1—glaucoma	4.18e-06	8.7e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—APOE—glaucoma	4.18e-06	8.7e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—CDKN2B—glaucoma	4.18e-06	8.7e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—CAV1—glaucoma	4.14e-06	8.62e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—FN1—glaucoma	4.11e-06	8.57e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—NTRK1—glaucoma	4.11e-06	8.56e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—NTRK1—glaucoma	4.1e-06	8.54e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—NTRK1—glaucoma	4.09e-06	8.52e-05	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—APOE—glaucoma	4.08e-06	8.49e-05	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—MTHFR—glaucoma	4.08e-06	8.49e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—NTRK1—glaucoma	4.08e-06	8.49e-05	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—APOE—glaucoma	4.07e-06	8.48e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—BAD—glaucoma	4.06e-06	8.46e-05	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—CAV1—glaucoma	4.04e-06	8.41e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—NTRK1—glaucoma	4.04e-06	8.41e-05	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—CAV1—glaucoma	4.03e-06	8.4e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—NTRK1—glaucoma	4.03e-06	8.38e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—EDN1—glaucoma	4.01e-06	8.35e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—GSTT1—glaucoma	4e-06	8.33e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	3.99e-06	8.3e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	3.95e-06	8.23e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—FN1—glaucoma	3.94e-06	8.2e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—APOE—glaucoma	3.93e-06	8.18e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—BAD—glaucoma	3.89e-06	8.11e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—CAV1—glaucoma	3.89e-06	8.1e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—NGF—glaucoma	3.87e-06	8.05e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CDKN2B—glaucoma	3.85e-06	8.02e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—NGF—glaucoma	3.85e-06	8.01e-05	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—APOE—glaucoma	3.8e-06	7.9e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CDKN2B—glaucoma	3.79e-06	7.89e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CDKN2B—glaucoma	3.78e-06	7.87e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CDKN2B—glaucoma	3.77e-06	7.85e-05	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—MTHFR—glaucoma	3.77e-06	7.84e-05	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—CAV1—glaucoma	3.76e-06	7.83e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CDKN2B—glaucoma	3.76e-06	7.82e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CDKN2B—glaucoma	3.72e-06	7.75e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CDKN2B—glaucoma	3.71e-06	7.73e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—FN1—glaucoma	3.7e-06	7.71e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—EDN1—glaucoma	3.69e-06	7.69e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—NGF—glaucoma	3.68e-06	7.67e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—C3—glaucoma	3.68e-06	7.66e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—GSTM1—glaucoma	3.67e-06	7.63e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—BAD—glaucoma	3.66e-06	7.62e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—C3—glaucoma	3.66e-06	7.62e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—EDN1—glaucoma	3.64e-06	7.57e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—EDN1—glaucoma	3.63e-06	7.55e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—EDN1—glaucoma	3.62e-06	7.53e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—EDN1—glaucoma	3.6e-06	7.51e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—GSTM1—glaucoma	3.59e-06	7.48e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—EDN1—glaucoma	3.57e-06	7.43e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—EDN1—glaucoma	3.56e-06	7.41e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	3.51e-06	7.3e-05	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—APOE—glaucoma	3.51e-06	7.3e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—C3—glaucoma	3.5e-06	7.29e-05	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—CAV1—glaucoma	3.47e-06	7.23e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—ABCA1—glaucoma	3.46e-06	7.22e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—CYP1B1—glaucoma	3.46e-06	7.22e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—NOS3—glaucoma	3.46e-06	7.21e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—NOS3—glaucoma	3.46e-06	7.21e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—APOE—glaucoma	3.42e-06	7.13e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—APOE—glaucoma	3.4e-06	7.09e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—NGF—glaucoma	3.4e-06	7.07e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—CAV1—glaucoma	3.39e-06	7.06e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—GSTT1—glaucoma	3.39e-06	7.06e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—ABCA1—glaucoma	3.38e-06	7.04e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—CYP1B1—glaucoma	3.38e-06	7.04e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—CAV1—glaucoma	3.37e-06	7.03e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—TXN—glaucoma	3.37e-06	7.02e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—NGF—glaucoma	3.34e-06	6.96e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—NGF—glaucoma	3.33e-06	6.94e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—NGF—glaucoma	3.32e-06	6.92e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—NGF—glaucoma	3.31e-06	6.9e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—NGF—glaucoma	3.28e-06	6.83e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—NGF—glaucoma	3.27e-06	6.81e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—NOS3—glaucoma	3.27e-06	6.8e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—APOE—glaucoma	3.26e-06	6.79e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—MTHFR—glaucoma	3.24e-06	6.75e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—CAV1—glaucoma	3.23e-06	6.73e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—C3—glaucoma	3.23e-06	6.72e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—FN1—glaucoma	3.23e-06	6.72e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—FN1—glaucoma	3.21e-06	6.69e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—BAD—glaucoma	3.19e-06	6.64e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—ABCA1—glaucoma	3.19e-06	6.64e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—CYP1B1—glaucoma	3.19e-06	6.64e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—C3—glaucoma	3.18e-06	6.61e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—MTHFR—glaucoma	3.17e-06	6.61e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—BAD—glaucoma	3.17e-06	6.61e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—C3—glaucoma	3.17e-06	6.6e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—C3—glaucoma	3.16e-06	6.58e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—C3—glaucoma	3.15e-06	6.56e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—NOS3—glaucoma	3.13e-06	6.52e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—C3—glaucoma	3.12e-06	6.49e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—C3—glaucoma	3.11e-06	6.48e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—FN1—glaucoma	3.07e-06	6.4e-05	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—NOS3—glaucoma	3.06e-06	6.36e-05	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—NOS3—glaucoma	3.05e-06	6.35e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—BAD—glaucoma	3.04e-06	6.33e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—APOE—glaucoma	3.02e-06	6.28e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—APOE—glaucoma	3e-06	6.26e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—CDKN1B—glaucoma	3e-06	6.25e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—CDKN1B—glaucoma	3e-06	6.24e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—CAV1—glaucoma	2.99e-06	6.22e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CAV1—glaucoma	2.98e-06	6.2e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—APOE—glaucoma	2.96e-06	6.16e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—APOE—glaucoma	2.95e-06	6.15e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—APOE—glaucoma	2.95e-06	6.14e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—NOS3—glaucoma	2.94e-06	6.13e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—APOE—glaucoma	2.94e-06	6.12e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—APOE—glaucoma	2.93e-06	6.11e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CAV1—glaucoma	2.93e-06	6.1e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—CAV1—glaucoma	2.93e-06	6.1e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CAV1—glaucoma	2.92e-06	6.09e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CAV1—glaucoma	2.91e-06	6.07e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CAV1—glaucoma	2.9e-06	6.05e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—APOE—glaucoma	2.9e-06	6.05e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—APOE—glaucoma	2.89e-06	6.03e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CAV1—glaucoma	2.88e-06	5.99e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CAV1—glaucoma	2.87e-06	5.97e-05	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—NOS3—glaucoma	2.84e-06	5.92e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—FN1—glaucoma	2.83e-06	5.9e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—CDKN1B—glaucoma	2.83e-06	5.89e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—BAD—glaucoma	2.8e-06	5.83e-05	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—PTGS2—glaucoma	2.79e-06	5.82e-05	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—PTGS2—glaucoma	2.79e-06	5.81e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—FN1—glaucoma	2.79e-06	5.81e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—FN1—glaucoma	2.78e-06	5.79e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—MMP9—glaucoma	2.78e-06	5.79e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—MMP9—glaucoma	2.78e-06	5.78e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—FN1—glaucoma	2.77e-06	5.78e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—GSTM1—glaucoma	2.77e-06	5.77e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—FN1—glaucoma	2.76e-06	5.76e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—BAD—glaucoma	2.76e-06	5.74e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—BAD—glaucoma	2.75e-06	5.73e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—BAD—glaucoma	2.74e-06	5.71e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—FN1—glaucoma	2.74e-06	5.7e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.73e-06	5.69e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—BAD—glaucoma	2.73e-06	5.69e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—FN1—glaucoma	2.73e-06	5.69e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—CDKN1B—glaucoma	2.71e-06	5.64e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—BAD—glaucoma	2.71e-06	5.63e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—GSTM1—glaucoma	2.7e-06	5.63e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—ABCA1—glaucoma	2.7e-06	5.62e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—CYP1B1—glaucoma	2.7e-06	5.62e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—BAD—glaucoma	2.7e-06	5.62e-05	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—NOS3—glaucoma	2.63e-06	5.47e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—MMP9—glaucoma	2.62e-06	5.46e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—GSTT1—glaucoma	2.61e-06	5.45e-05	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—PTGS2—glaucoma	2.6e-06	5.42e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—NOS3—glaucoma	2.56e-06	5.34e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—NOS3—glaucoma	2.55e-06	5.31e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—CDKN1B—glaucoma	2.55e-06	5.31e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—GSTM1—glaucoma	2.55e-06	5.31e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—MMP9—glaucoma	2.51e-06	5.23e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—VEGFA—glaucoma	2.5e-06	5.2e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—VEGFA—glaucoma	2.49e-06	5.19e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—MTHFR—glaucoma	2.45e-06	5.1e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—NOS3—glaucoma	2.44e-06	5.09e-05	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—PTGS2—glaucoma	2.4e-06	5e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—MTHFR—glaucoma	2.39e-06	4.98e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—MMP9—glaucoma	2.36e-06	4.92e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—VEGFA—glaucoma	2.35e-06	4.9e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—APOE—glaucoma	2.28e-06	4.75e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—NOS3—glaucoma	2.26e-06	4.71e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—CAV1—glaucoma	2.26e-06	4.7e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—VEGFA—glaucoma	2.25e-06	4.69e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—MTHFR—glaucoma	2.25e-06	4.69e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—NOS3—glaucoma	2.25e-06	4.69e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—APOE—glaucoma	2.22e-06	4.63e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—CDKN1B—glaucoma	2.22e-06	4.63e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—NOS3—glaucoma	2.21e-06	4.61e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—NOS3—glaucoma	2.21e-06	4.61e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—NOS3—glaucoma	2.21e-06	4.6e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—CDKN1B—glaucoma	2.21e-06	4.6e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—CAV1—glaucoma	2.2e-06	4.59e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—NOS3—glaucoma	2.2e-06	4.59e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—NOS3—glaucoma	2.2e-06	4.57e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—NOS3—glaucoma	2.17e-06	4.53e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—NOS3—glaucoma	2.17e-06	4.52e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—GSTM1—glaucoma	2.16e-06	4.49e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—VEGFA—glaucoma	2.12e-06	4.41e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—CDKN1B—glaucoma	2.12e-06	4.41e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—APOE—glaucoma	2.1e-06	4.37e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—ABCA1—glaucoma	2.08e-06	4.34e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—CYP1B1—glaucoma	2.08e-06	4.34e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—CAV1—glaucoma	2.08e-06	4.33e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—PTGS2—glaucoma	2.07e-06	4.3e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—MMP9—glaucoma	2.06e-06	4.28e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—MMP9—glaucoma	2.05e-06	4.26e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—PTGS2—glaucoma	2.02e-06	4.22e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—MMP9—glaucoma	1.96e-06	4.08e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CDKN1B—glaucoma	1.95e-06	4.06e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CDKN1B—glaucoma	1.92e-06	4e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CDKN1B—glaucoma	1.91e-06	3.99e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CDKN1B—glaucoma	1.91e-06	3.97e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—MTHFR—glaucoma	1.91e-06	3.97e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CDKN1B—glaucoma	1.9e-06	3.96e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—TP53—glaucoma	1.89e-06	3.93e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CDKN1B—glaucoma	1.88e-06	3.92e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—TP53—glaucoma	1.88e-06	3.92e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CDKN1B—glaucoma	1.88e-06	3.91e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—VEGFA—glaucoma	1.85e-06	3.85e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—VEGFA—glaucoma	1.84e-06	3.83e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—MMP9—glaucoma	1.81e-06	3.76e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—TP53—glaucoma	1.78e-06	3.7e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—MMP9—glaucoma	1.78e-06	3.7e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—APOE—glaucoma	1.78e-06	3.7e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—MMP9—glaucoma	1.77e-06	3.69e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—MMP9—glaucoma	1.77e-06	3.68e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—MMP9—glaucoma	1.76e-06	3.67e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—CAV1—glaucoma	1.76e-06	3.66e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—VEGFA—glaucoma	1.76e-06	3.66e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—MMP9—glaucoma	1.74e-06	3.63e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—MMP9—glaucoma	1.74e-06	3.62e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—NOS3—glaucoma	1.71e-06	3.56e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—TP53—glaucoma	1.7e-06	3.55e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—NOS3—glaucoma	1.67e-06	3.47e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—GSTM1—glaucoma	1.67e-06	3.47e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—VEGFA—glaucoma	1.62e-06	3.38e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—TP53—glaucoma	1.6e-06	3.34e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—VEGFA—glaucoma	1.6e-06	3.32e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—VEGFA—glaucoma	1.59e-06	3.32e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—VEGFA—glaucoma	1.59e-06	3.31e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—VEGFA—glaucoma	1.58e-06	3.3e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—NOS3—glaucoma	1.57e-06	3.27e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—VEGFA—glaucoma	1.57e-06	3.26e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—VEGFA—glaucoma	1.56e-06	3.25e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—PTGS2—glaucoma	1.56e-06	3.25e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—PTGS2—glaucoma	1.52e-06	3.17e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—MTHFR—glaucoma	1.47e-06	3.07e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—PTGS2—glaucoma	1.44e-06	2.99e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—TP53—glaucoma	1.4e-06	2.91e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—TP53—glaucoma	1.39e-06	2.89e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—APOE—glaucoma	1.37e-06	2.85e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—CAV1—glaucoma	1.36e-06	2.83e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—NOS3—glaucoma	1.33e-06	2.77e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—TP53—glaucoma	1.33e-06	2.77e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—TP53—glaucoma	1.23e-06	2.55e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—PTGS2—glaucoma	1.22e-06	2.53e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—TP53—glaucoma	1.21e-06	2.51e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—TP53—glaucoma	1.2e-06	2.51e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—TP53—glaucoma	1.2e-06	2.5e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—TP53—glaucoma	1.2e-06	2.49e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—TP53—glaucoma	1.18e-06	2.47e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—TP53—glaucoma	1.18e-06	2.46e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—NOS3—glaucoma	1.03e-06	2.14e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PTGS2—glaucoma	9.39e-07	1.96e-05	CbGpPWpGaD
